Skip to content 
- [PRESSWIRE] Vienna – 30th June 2020 — Eveliqure Biotechnologies today announces that further financing has been secured from Arax Capital Partners comprising the last instalment of a €1.7M total investment provided by Arax. This is complemented by further private investment from Baobá and a Swiss based family office, and totals around €0.5M.
- [PRESSWIRE] Vienna – 4 June, 2020 — The Austrian biotech company CEBINA GmbH announces that it has received seed funding for its extended spectrum Coronavirus vaccine project, which is part of CEBINA’s broad-scale efforts offering short-, mid- and longer-term solutions to fight the COVID-19 pandemic. This seed funding will support proof-of-concept studies of the vaccine that will allow progress to pre-clinical development, scheduled for Q1/2021. The funds are provided by the Blom Family Office.
- [PRESSWIRE] Vienna – 2nd June 2020 — Eveliqure Biotechnologies today, announces that the Hungarian regulatory agency OGYÈI has approved the clinical trial for its vaccine program to prevent diarrhoeal diseases caused by Shigella and Enterotoxigenic E. coli (ETEC).
- [PRESSWIRE] Frankfurt a. M., Germany & Haarlem, The Netherlands – 17 May, 2020 — FIZ (Frankfurt Biotechnology Innovation Center GmbH) and Sri Sri Tattva Europe B.V. collaborate to fight against COVID-19 through Ayurveda.
- [PRESSWIRE] Luxembourg – 14 May, 2020 — The pandemic has taken the medical world by surprise and challenged the medical device industry, putting a heavy strain on manufacturers. How does a CEO juggle between the intensifying demand for reliable medical equipment, the need for innovations, and the safety of his employees to make sure that COVID-19 is behind us in the shortest time possible?
- [PRESSWIRE] Austria – 20 April, 2020 — Austrian biotech company Calyxha Biotechnologies GmbH is pleased to announce the grant of European Patent No. EP3383381. This patent covers the use of calixarene compounds for neurodegenerative diseases, including Parkinson’s disease. It represents the company’s first granted patent, with prosecution of the corresponding patent applications ongoing in other territories.
- [PRESSWIRE] Stockholm, Sweden – 7 April, 2020 — Cobra Biologics and the world-renowned medical university Karolinska Institute join forces in the fight against Covid-19.
- [PRESSWIRE] UK – 02.04.20 — RWS has mobilized its global research community to find scientific information that might be beneficial to pharmaceutical companies working on Covid-19 vaccines or treatments.
- [PRESSWIRE] Chicago, IL United States – 19 March, 2020 — Surgisphere has developed a COVID-19 triage tool that helps prioritize care for patients who are in urgent need of care.
- [PRESSWIRE] Atlanta, Ga. – 14 gennaio 2020 — Il Team Novo Nordisk, la prima squadra ciclistica professionistica al mondo interamente composta da corridori con diabete, correrà la stagione 2020 su telai Colnago completi di componenti, freni a disco e misuratori di potenza Shimano di2, indossando kit progettati dalla GSG.
- [PRESSWIRE] DENVER, Oct. 24, 2019 — Aspen Laser Systems, LLC, an emerging leader in laser therapy, also referred to as Photobiomodulation, announced that it has been recognized with an award by Global Health & Pharma, a leading publication and information sharing platform, dedicated to the healthcare industry.
- [PRESSWIRE] Netherlands – 11 July, 2019 — With a clear vision in mind Iperion Life Sciences Consultancy has taken the next step in realizing her mission. As of July 1st Remco Munnik will join Iperion to strengthen the team. Munnik will be responsible for sales team leadership, extension of subject matter expertise and service delivery, contributions to telematics topics throughout the international network, as well as giving workshops and training.
- [PRESSWIRE] LONDON, July 5, 2019 — Cancer treating drugs market forms the most lucrative sector in pharmaceuticals. As the ageing population continues to rise across the world, the incidence of cancer will continue to grow, leading to increased spending on cancer-treating medicines. This report lists and discusses the top 30 oncology drugs manufacturers.
- [PRESSWIRE] Weimar, Germany – 29 October, 2018 — The renewed interest in anti-GBM disease is spurred by the detection of autoantibodies in other forms of glomerulonephritis and has led to an exciting development in studies on pathogenesis as well as diagnosis and management. The newly published review [1] by Professor Mårten Segelmark, gives a comprehensive update on Anti-GBM disease subgroups, pathogenesis and therapies. “A must-read for all nephrologist”, explains Professor Denis Fouque, editor-in-chief of Nephrology Dialysis and Transplantation (NDT), the journal in which the review was published.
- [PRESSWIRE] SEATTLE and VANCOUVER, British Columbia, Sept. 27, 2018 — Achieve Life Sciences, Inc. (NASDAQ :ACHV ), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced results of a clinical study evaluating the effect of food on the bioavailability of a new formulation for cytisine.
- [PRESSWIRE] ‘s-Hertogenbosch, The Netherlands – 5 July, 2018 — A total grant sum of EUR 2 million has been awarded to a multidisciplinary EUROSTARS consortium. The EUROSTARS project is titled “Treatment Response Monitoring for Cancer Immunotherapies Using Immune Repertoire Analysis” and named IMMUNOMONITOR.
- [PRESSWIRE] Germany – 27 June, 2018 — Kidney diseases have so far been underestimated in many respects: most people are not aware of their impaired kidney function. In general, kidney diseases are “silent diseases”, most often there are no apparent early symptoms. Many people with kidney diseases are not aware that they have been living with higher risks of cardiovascular diseases, infections, hospitalizations, and of course kidney failure which requires dialysis or transplantation.
- [PRESSWIRE] LONDON, June 19, 2018 — While the automotive and electronics industries, among others, have been relatively fast in adopting robotics, pharma has been lagging behind.
- [PRESSWIRE] Boston, MA – June 12, 2018 — Zaluvida a global life science group, announced today the formation of a Scientific Advisory Board (SAB) to inform the Human Health Research & Development department about the latest research, scientific methods, and opportunities for weight-loss management, and help further technology and product development for the company.
- [PRESSWIRE] London, United Kingdom — 11 April, 2018 – To coincide with this month’s WORLD MALARIA DAY and THECOMMONWEALTH CONFERENCE which has malaria prevention high on the agenda, Vectorcide International Ltd www.vectorcide.co.uk – a private UK company – announces their breakthrough-coating product (containing a WHO approved active ingredient) to combat and kill the female mosquito: the carrier of diseases such as Malaria, Dengue, Zika, etc.
- [PRESSWIRE] AACHEN, Germany and LEUVEN, Belgium, April 9, 2018 — Grünenthal, the Katholieke Universiteit Leuven’s Centre for Drug Design and Discovery (CD3) and the Laboratory of Ion Channel Research (LICR) announced today that they have entered into a research collaboration for the development of novel non-opioid drug candidates for the treatment of painful diseases with a high unmet medical need.
- [PRESSWIRE] HUDDINGE, Sweden, March 23, 2018 — Karo Pharma has decided to support Operation Smile with a donation of 2,5 MSEK.
- [PRESSWIRE] LONDON, March 5, 2018 — PharmaBoardroom today releases its new 60-page Healthcare & Life Sciences Review Brazil 2018.
- [PRESSWIRE] LONDON, March 2, 2018 — New Zealand deer velvet supplier Velvet Energy UK has given its support to a multi-million dollar investment made by one of South Korea’s largest pharmaceutical companies.
- [PRESSWIRE] ANN ARBOR, Michigan, Feb. 13, 2018 — NSF International, a global public health and safety organization, recently signed a two-year partnership with the Institute of National Anti-Doping Organisations (iNADO) based in Bonn, Germany. With the partnership, iNADO recognizes NSF’s Certified for Sport® program as an invaluable resource to help athletes and consumers avoid potentially harmful ingredients and athletic banned substances found in dietary supplements.
- [PRESSWIRE] Vlijmen, The Netherlands – 05 February, 2018 — Iperion Life Sciences Consultancy (Iperion) has acquired US based Identifica’s regulatory consulting practice. The acquisition is a logical step in Iperion’s ambition to become a global specialists in regulatory consultancy. The consultancy and related regulatory services will be available via offices in Netherlands and Boston (USA) in support of European, US and Canadian based life sciences customers. As a result of the acquisition expertise is now available in support of both industry as well as regulators.
- [PRESSWIRE] CAMBRIDGE, England, January 4, 2018 — Acacia Pharma Group Ltd (“Acacia Pharma”), a pharmaceutical company developing and commercialising hospital products for US and international markets, announces that the New Drug Application (NDA) for BAREMSIS®(amisulpride injection, formerly APD421) for the management of post-operative nausea & vomiting (PONV), has been accepted for filing by the US Food and Drug Administration (FDA). Under the Prescription Drug User Fee Act (PDUFA), the FDA has set a target date of 5th October 2018 to complete its review.
- [PRESSWIRE] YONGIN, South Korea, Jan. 2, 2018 — Green Cross Holdings Corporation (KRX: 005250), a holding company for Green Cross Corporation, a leading biopharmaceutical company, and healthcare related businesses, today unveiled its new strategic master brand that promotes the simplified “GC” name as a global corporate asset, along with a new visual identity designed to become a universally recognizable symbol.
- [PRESSWIRE] LONDON, October 27, 2017 — One of Britain’s most respected dermatologists has hailed as ‘miraculous’ a non-steroid treatment for psoriasis following its first efficacy trials in the UK.
- [PRESSWIRE] New York – 30 October, 2017 — PharmaBoardroom today releases its new 51-page Healthcare & Life Sciences Review Colombia 2017.
